Surgical management for overactive bladder

被引：4
作者：
Appell R.A. [1 ]
Boone T.B. [1 ]
机构：
[1] Department of Urology, Baylor College of Medicine, Houston, TX, 77030
来源：
Current Bladder Dysfunction Reports | 2007年 / 2卷 / 1期
关键词：
Overactive Bladder; Urge Incontinence; Interstitial Cystitis; Urinary Diversion; Pudendal Nerve;
D O I：
10.1007/s11884-007-0032-x
中图分类号：
学科分类号：
摘要：
The majority of patients with overactive bladder can be managed with office-based techniques. When medical therapy fails as treatment for overactive bladder, surgical intervention ranging from electrical stimulation administered in the office to extensive procedures, such as augmentation or urinary diversion, may be needed. Any surgical intervention should be tailored to the patient with consideration of the degree of his or her discomfort, underlying pathology, general health, and obviously the patient's own motivation. © 2007 Springer Science+Business Media, LLC.
引用
收藏
页码：37 / 45
页数：8
相关论文
共 49 条
[21]  
Klingler H.C., Pycha A., Schmidbauer J., Et al., Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study, Urology, 56, pp. 766-771, (2000)
[22]  
Govier F.E., Litwiller S., Nitti V., Et al., Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study, J Urol, 165, pp. 1193-1198, (2001)
[23]  
Juenemann K.P., Lue T.F., Schmidt R.A., Et al., Clinical significance of sacral and pudendal nerve anatomy, J Urol, 139, pp. 74-80, (1988)
[24]  
Koldewijn E.L., Rosier P.F., Meuleman E.J., Et al., Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients, J Urol, 152, pp. 2071-2075, (1994)
[25]  
Janknegt R.A., Hassouna M.M., Siegel S.W., Et al., Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence, Eur Urol, 39, pp. 101-106, (2001)
[26]  
Schurch B., Stohrer M., Kramer G., Et al., Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results, J Urol, 164, pp. 692-697, (2000)
[27]  
Grosse J., Kramer G., Stohrer M., Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrosor overactivity and incontinence, Eur Urol, 47, pp. 653-659, (2005)
[28]  
Leippold T., Reitz A., Schurch B., Botulinum toxin as a new therapy option for voiding disorders: current state of the art, Eur Urol, 44, pp. 165-174, (2003)
[29]  
Rapp D.E., Lucioni A., Katz E.E., Et al., Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience, Urology, 63, pp. 1071-1075, (2004)
[30]  
Cartwright P.C., Snow B.W., Bladder autoaugmentation: early clinical experience, J Urol, 142, pp. 505-508, (1989)
12345